Clinical Trial

Polish Version Dyspnea in Amyotrophic Lateral Sclerosis

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Amyotrophic lateral sclerosis is a fatal disease with progressive degeneration of central and peripheral motor neurons. Weakness of pharyngeal and respiratory muscles lead to dyspnea, which is present in up to 80% of patients. Dyspnea in Amyotrophic Lateral Sclerosis (DALS-15) is a questionnaire designed to measure the severity of dyspnea. DALS-15 was originally created in German language. The aim of this study is to validate the Polish-language version of DALS-15.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-10.
Trial Details
NCT Number NCT07178574
Lead Sponsor Jakub Antczak
Conditions Amyotrophic Lateral Sclerosis
Enrollment 120 participants
Start Date 2025-10-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-19